Prognostic Significance of HER2-Low Status in HR+/HER2− Advanced Breast Cancer Treated With CDK4/6 Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
NPJ breast cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors
NPJ Breast Cancer 2023 Apr 17;9(1)27, E Zattarin, D Presti, L Mariani, C Sposetti, R Leporati, A Menichetti, C Corti, C Benvenuti, G Fucà, R Lobefaro, F Ligorio, L Provenzano, A Vingiani, M Del Vecchio, G Griguolo, M Sirico, O Bernocchi, A Marra, P Zagami, E Agostinetto, F Jacobs, P Di Mauro, A Esposito, CA Giorgi, L Lalli, L Boldrini, PPB Giacchetti, AC Schianca, V Guarneri, R Pedersini, A Losurdo, A Zambelli, D Generali, C Criscitiello, G Curigliano, G Pruneri, F de Braud, MV Dieci, C VernieriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.